2025 annual financial data
Drugs Made In America Acquisition II 2025 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -1,300,498 USD and net income was 4,187,050 USD.
Operating cash flow was -1,018,231 USD.
Get free Drugs Made In America Acquisition II email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,300,498 USD
- Net income
- 4,187,050 USD
- Operating cash flow
- -1,018,231 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Drugs Made In America Acquisition II financial years